- Home
- ACHV vs AXR Comparison
ACHV vs AXR Comparison
Compare ACHV & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- AXR
- Stock Information
- Founded
- ACHV N/A
- AXR 1961
- Country
- ACHV Canada
- AXR United States
- Employees
- ACHV N/A
- AXR N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AXR Homebuilding
- Sector
- ACHV Health Care
- AXR Real Estate
- Exchange
- ACHV Nasdaq
- AXR Nasdaq
- Market Cap
- ACHV 159.0M
- AXR 155.7M
- IPO Year
- ACHV N/A
- AXR N/A
- Fundamental
- Price
- ACHV $4.98
- AXR $29.66
- Analyst Decision
- ACHV Strong Buy
- AXR
- Analyst Count
- ACHV 4
- AXR 0
- Target Price
- ACHV $15.50
- AXR N/A
- AVG Volume (30 Days)
- ACHV 112.5K
- AXR 12.2K
- Earning Date
- ACHV 11-07-2024
- AXR 12-09-2024
- Dividend Yield
- ACHV N/A
- AXR N/A
- EPS Growth
- ACHV N/A
- AXR N/A
- EPS
- ACHV N/A
- AXR 1.76
- Revenue
- ACHV N/A
- AXR $60,171,000.00
- Revenue This Year
- ACHV N/A
- AXR N/A
- Revenue Next Year
- ACHV N/A
- AXR N/A
- P/E Ratio
- ACHV N/A
- AXR $16.79
- Revenue Growth
- ACHV N/A
- AXR 24.69
- 52 Week Low
- ACHV $3.03
- AXR $15.38
- 52 Week High
- ACHV $5.98
- AXR $31.26
- Technical
- Relative Strength Index (RSI)
- ACHV 56.44
- AXR 61.67
- Support Level
- ACHV $4.85
- AXR $27.20
- Resistance Level
- ACHV $5.13
- AXR $29.59
- Average True Range (ATR)
- ACHV 0.18
- AXR 1.03
- MACD
- ACHV -0.01
- AXR -0.27
- Stochastic Oscillator
- ACHV 43.40
- AXR 82.00
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.